Intelligence Platform

Patents

Browse 1,015 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9701740

Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9694071

Combination of anti-CD20 antibody and PI3 kinase selective inhibitor

TG Therapeutics, Inc. · Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9695246

Anti-OX40 antibodies and methods of using the same

The Board of Regents of the University of Texas System · Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9688748

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and m

CytomX Therapeutics, Inc. · Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9688764

Methods of treating breast cancer by administering anti-human prolactin receptor (PRLR) an

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9676869

Conjugated anti-CD38 antibodies

Takeda Pharmaceutical Company Limited · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9675692

Stabilized formulations containing anti-DLL4 antibodies

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9676840

Anti-CD100 neutralizing antibodies and methods of using the same

VACCINEX, INC. · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9669064

Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteina

China Medical University · Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9663585

Anti-DCLK1 monoclonal antibodies and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9657102

Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9656001

Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applicati

The Board of Regents of the University of Texas System · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9657090

Method of treating alveolar bone loss through the use of anti-sclerostin antibodies

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9657099

Anti-glucagon antibodies

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9650444

Anti-PDGFR-beta antibodies and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9642391

Anti-regurgitation composition maintaining gut motility

UNITED PHARMACEUTICALS · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9636412

Conjugates of an anti-TNF-alpha antibody

Nektar Therapeutics · Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9624211

Anti-cancer compounds

The Board of Regents of the University of Texas System · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9624306

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of sa

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9624303

Single-chain variable fragment anti-CD133 antibodies and uses thereof

Regents of the University of Minnesota · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9616048

Anti-depression compounds

The Board of Regents of the University of Texas System · Granted Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9611266

Compounds and anti-tumor NQO1 substrates

The Board of Regents of the University of Texas System · Granted Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9604973

Anti-cancer polyketide compounds

The Regents of the University of California · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9605055

Anti-CD100 antibodies and methods of using the same

VACCINEX, INC. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted